Abstract
Purpose
To report the efficacy and safety of water vapor thermal therapy to achieve catheter removal in frail patients with refractory acute urinary retention.
Methods
Data from consecutive frail patients with indwelling urinary catheter undergoing the Rezūm™ therapy (Boston Scientific Corporation, Marlborough, MA) at a single center between October 2017 and June 2021 were prospectively collected. The included patients were deemed unfit or at high risk of complications for conventional benign prostatic hyperplasia (BPH) surgery. Prostate volumes up to 120 mL were considered eligible. The primary endpoint was successful cessation of catheter dependency, assessed postoperatively and up to 1 year of follow-up.
Results
A total of 24 men met our inclusion criteria. The median age, Charlson comorbidity index, and duration of preoperative catheterization were 77 years (IQR 67–86), 6 (IQR 3–7), and 113 days (IQR 87–159), respectively. Two cases (8.3%) of postoperative complications were recorded (Clavien II and Clavien IIIa). After a median postoperative catheterization time of 21 days (IQR 11–32), all patients regained spontaneous voiding. During follow-up, two patients died and a total of 22 patients completed the 1 year follow-up. All patients maintained spontaneous voiding without recurrence of urinary retention. No surgical retreatment was performed. In terms of pharmacological management, 22/24 patients (91.7%) had a BPH medication pre‐Rezūm™; this decreased to 8/22 patients (36.3%) post‐Rezūm™ (p < 0.001).
Conclusions
In this single-institution, prospective, and observational study, water vapor thermal therapy was found to be effective and safe in restoring successful spontaneous voiding in a cohort of elderly and frail patients.
Similar content being viewed by others
Availability of data and materials
Data are available upon request to the corresponding author.
Code availability
None.
References
Baboudjian M, Savoie PH, Long JA, Boissier R (2021) Rétention aiguë d’urines : épidémiologie, optimisation du parcours de soin et alternative au drainage permanent [Acute urine retention: epidemiology, optimization of the care pathway and alternative to permanent bladder drainage]. Prog Urol 31(15):967–977
Baboudjian M, Peyronnet B, Boissier R et al (2022) Best nonsurgical managements of acute urinary retention: what’s new? Curr Opin Urol 32(2):124–130
Fitzpatrick JM, Desgrandchamps F, Adjali K et al (2012) Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia. BJU Int 109(1):88–95
Gondran-Tellier B, McManus R, Sichez PC et al (2021) Efficacy and safety of surgery for benign prostatic obstruction in patients with preoperative urinary catheter. J Endourol 35(1):102–108
Kidd EA, Stewart F, Kassis NC, Hom E, Omar MI (2015) Urethral (indwelling or intermittent) or suprapubic routes for short-term catheterisation in hospitalised adults. Cochrane Database Syst Rev 12:004203
Malde S, Umbach R, Wheeler JR et al (2021) A systematic review of patients’ values, preferences, and expectations for the diagnosis and treatment of male lower urinary tract symptoms. Eur Urol 79(6):796–809
Madersbacher S, Roehrborn CG, Oelke M (2020) The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia. BJU Int 126(3):317–326
McVary KT, Gittelman MC, Goldberg KA et al (2021) Final 5 year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 206(3):715–724
Alegorides C, Fourmarier M, Eghazarian C, Lebdai S, Chevrot A, Droupy S (2020) Treatment of benign prostate hyperplasia using the Rezum® water vapor therapy system: Results at one year. Prog Urol 30(12):624–631
Baboudjian M, Alegorides C, Fourmarier M et al (2022) Comparison of water vapor thermal therapy and prostate artery embolization for fragile patients with indwelling urinary catheters: preliminary results from a multi-institutional study. Prog Urol 32(2):115–120
Gage H, Avery M, Flannery C, Williams P, Fader M (2017) Community prevalence of long-term urinary catheters use in England. Neurourol Urodyn 36(2):293–296
Sørbye LW, Finne-Soveri H, Ljunggren G, Topinková E, Bernabei R (2005) Indwelling catheter use in home care: elderly, aged 65+, in 11 different countries in Europe. Age Ageing 34(4):377–381
Evans A, Pheby D, Painter D, Feneley R (2000) The costs of long-term catheterization in the community. Br J Community Nurs 5(10):477–478
Reid S, Brocksom J, Hamid R et al (2021) British association of urological surgeons (BAUS) and nurses (BAUN) consensus document: management of the complications of long-term indwelling catheters. BJU Int 128(6):667–677
McVary KT, Holland B, Beahrs JR (2020) Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 23(2):303–308
Wong A, Mahmalji W (2020) The role of Rezūm ™ team ablation of the prostate in the treatment of patients with acute urinary retention secondary to benign prostatic hyperplasia. A single center, single surgeon case series and literature review. Aging Male 23(5):1620–1626
Elterman DS, Bhojani N, Vannabouathong C, Chughtai B, Zorn KC (2022) Rezūm water vapor therapy for catheter-dependent urinary retention: a real-world Canadian experience. Can J Urol 29(2):11075–11079
Eredics K, Wehrberger C, Henning A et al (2022) Rezūm water vapor therapy in multimorbid patients with urinary retention and catheter dependency. Prostate Cancer Prostatic Dis 25(2):302–305
Mynderse LA, Hanson D, Robb RA et al (2015) Rezūm system water vapor treatment for lower urinary tract symptoms/benign prostatic hyperplasia: validation of convective thermal energy transfer and characterization with magnetic resonance imaging and 3-dimensional renderings. Urology 86(1):122–127
Funding
The study was not funded.
Author information
Authors and Affiliations
Contributions
Study concept and design: F, T, and B. Acquisition of data: T, B, and A. Analysis and interpretation of data: F, T, and B. Drafting of the manuscript: F, T, and B. Critical revision of the manuscript for important intellectual content: A, E, and B. Statistical analysis: B.
Corresponding author
Ethics declarations
Conflicts of interest
The authors report no conflict of interest.
Ethics approval
All procedures performed in this study were in approval with the ethical standards of the institutional research committee (IRB 19–10-09) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Consent to participate
All patients provided oral and written consent to undergo Rezūm™ therapy, while it was a technique under development and knew that the data could be used for research purposes.
Consent for publication
All authors approve the submission.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tadrist, A., Baboudjian, M., Bah, M.B. et al. Water vapor thermal therapy for indwelling urinary catheter removal in frail patients. Int Urol Nephrol 55, 249–253 (2023). https://doi.org/10.1007/s11255-022-03408-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-022-03408-w